APR 10, 2019 12:00 PM PDT

Best Practices for Implementing NGS and Positioning for Future Growth: Perspectives from 2 Labs

Sponsored by: Illumina
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Executive Director of the Advanced Diagnostic Laboratories, Moffitt Cancer Center
    Biography
      Dr. Magliocco has over 25 years experience as a Professor, Researcher, Pathologist, Laboratory Director, Consultant, Tissue Banker, and public speaker. He is Board Certified in Anatomic Pathology and has extensive experience and sub-specialty expertise in Breast, Gyn, and Molecular Pathology. He has held continuous peer reviewed funding in translational research and his laboratory is currently investigating the mechanisms of ovarian cancer metastasis and treatment evasion. He has founded numerous molecular diagnostic laboratories in the USA and Canada, has published over 200 manuscripts in oncology, and holds numerous diagnostic technology patents. He is currently Executive Director of Esoteric Laboratory Services at the Moffitt Cancer, as well as Scientific Director for Moffitt Tissue Core, one of the largest bio banking programs in the world. He also directs the newly formed Moffitt Morsani Advanced Diagnostics Laboratories which is focused on accelerating development of new CLIA laboratory diagnostics. Dr Magliocco also directs fellowship programs in Molecular Diagnostics and Digital Pathology. He has held numerous national and international roles including Chair of Pathology for the Radiation Therapy and Oncology Clinical Trials group, member of the NCI GU steering committee, and member of the Canadian Cancer Clinical Trials Network Steering committee, as well as previous editorial position with the Journal of Surgical Oncology and is frequent reviewer for numerous other Oncology and Pathology Journals.
    • Laboratory Operations Director, Navican Precision Cancer Care
      Biography
        Keith Gligorich, PhD, is the Laboratory Operations Director at NAVICAN Precision Cancer Care, an Intermountain Healthcare Company. NAVICAN provides TheraMap™, an end-to-end solution helping oncologists and patients harness the power of precision genomics, clinical analytics, and patient services for optimal cancer management. Prior to joining NAVICAN, Dr. Gligorich was a Research Assistant Professor in the Department of Pathology at the University of Utah and a Lead Scientist at ARUP Laboratories. In this role, he led a team of scientists focused on developing solid tumor molecular and NGS diagnostic tests. Dr. Gligorich earned a PhD in Chemistry from the University of Utah. He continued his training as a Department of Defense Breast Cancer Research Program Post-Doctoral Fellow at the Huntsman Cancer Institute.

      Abstract

      Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and community based cancer medical center – provided their perspectives on how they approach the challenge of addressing this need. The speakers will present on the reasons why they chose to internalize NGS testing, the value it brings to their healthcare system/network and what was involved to actualize their programs. Digital analytics and analysis employed by LTS Health was incorporated to provide feedback on the impact to laboratory operations and forecasting for future growth.  

      Learning Objectives: 

      1. Recognize the biomarkers that prompt the need for a multi-gene panel to maximize testing results from a single tissue biopsy. 
      2. List the attributes of a Comprehensive Genomics Panel that would be used to drive personalized medicine testing using NGS (next-generation sequencing). 
      3. Describe the Molecular Tumor Board considerations when doing case reviews. 
      4. Identify the components of a Quality Management System for NGS (next-generation sequencing) workflows. 


      Show Resources
      You May Also Like
      APR 07, 2020 8:00 AM PDT
      C.E. CREDITS
      APR 07, 2020 8:00 AM PDT
      DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
      JAN 23, 2020 9:00 AM PST
      C.E. CREDITS
      JAN 23, 2020 9:00 AM PST
      DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
      MAY 08, 2020 10:00 AM PDT
      C.E. CREDITS
      MAY 08, 2020 10:00 AM PDT
      DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
      JUN 09, 2020 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      JUN 09, 2020 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
      MAR 03, 2020 9:00 AM JST
      C.E. CREDITS
      MAR 03, 2020 9:00 AM JST
      DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
      FEB 25, 2020 9:00 AM PST
      C.E. CREDITS
      FEB 25, 2020 9:00 AM PST
      Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
      Loading Comments...
      Show Resources
      Attendees
      • See more